Paragonix SherpaPak™ Cardiac Transport System to be Featured in Clinical Presentation at 2019 American Transplant Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor organ heart transport and storage, will be featured in a clinical presentation at the 2019 American Transplant Congress. The meeting is being held June 1-5, 2019 in Boston.